BAIVF
Price
$0.22
Change
-$0.00 (-0.00%)
Updated
Feb 14 closing price
Capitalization
16.12M
CLYM
Price
$1.15
Change
-$0.06 (-4.96%)
Updated
Apr 3, 04:59 PM (EDT)
Capitalization
81.65M
46 days until earnings call
Ad is loading...

BAIVF vs CLYM

Header iconBAIVF vs CLYM Comparison
Open Charts BAIVF vs CLYMBanner chart's image
BENEVOLENTAI
Price$0.22
Change-$0.00 (-0.00%)
Volume$500
Capitalization16.12M
Climb Bio
Price$1.15
Change-$0.06 (-4.96%)
Volume$2.68K
Capitalization81.65M
BAIVF vs CLYM Comparison Chart
Loading...
CLYM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BAIVF vs. CLYM commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BAIVF is a StrongBuy and CLYM is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (BAIVF: $0.22 vs. CLYM: $1.21)
Brand notoriety: BAIVF and CLYM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BAIVF: 54% vs. CLYM: 42%
Market capitalization -- BAIVF: $16.12M vs. CLYM: $77.6M
BAIVF [@Biotechnology] is valued at $16.12M. CLYM’s [@Biotechnology] market capitalization is $77.6M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BAIVF’s FA Score shows that 1 FA rating(s) are green whileCLYM’s FA Score has 1 green FA rating(s).

  • BAIVF’s FA Score: 1 green, 4 red.
  • CLYM’s FA Score: 1 green, 4 red.
According to our system of comparison, both BAIVF and CLYM are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLYM’s TA Score shows that 5 TA indicator(s) are bullish.

  • CLYM’s TA Score: 5 bullish, 3 bearish.

Price Growth

BAIVF (@Biotechnology) experienced а 0.00% price change this week, while CLYM (@Biotechnology) price change was -6.92% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.57%. For the same industry, the average monthly price growth was -10.69%, and the average quarterly price growth was -14.76%.

Reported Earning Dates

CLYM is expected to report earnings on May 19, 2025.

Industries' Descriptions

@Biotechnology (-8.57% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CLYM($81.6M) has a higher market cap than BAIVF($16.1M). CLYM YTD gains are higher at: -32.778 vs. BAIVF (-47.619).
BAIVFCLYMBAIVF / CLYM
Capitalization16.1M81.6M20%
EBITDAN/A-24.57M-
Gain YTD-47.619-32.778145%
P/E RatioN/AN/A-
RevenueN/A0-
Total CashN/A193M-
Total DebtN/A58K-
TECHNICAL ANALYSIS
Technical Analysis
CLYM
RSI
ODDS (%)
Bullish Trend 7 days ago
71%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
79%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 7 days ago
73%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 11 days ago
77%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
75%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
CLYM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PCHSX32.14N/A
N/A
Putnam Global Health Care C
ITRIX28.26N/A
N/A
VY® T. Rowe Price Capital Apprec I
REICX12.55N/A
N/A
West Loop Realty C
SLFYX8.14N/A
N/A
SEI Multi-Asset Inflation Mgd Y (SIMT)
SJGAX28.28N/A
N/A
Steward Large Cap Growth A

BAIVF and

Correlation & Price change

A.I.dvisor tells us that BAIVF and BMEA have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BAIVF and BMEA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BAIVF
1D Price
Change %
BAIVF100%
N/A
BMEA - BAIVF
32%
Poorly correlated
+8.54%
RLYB - BAIVF
24%
Poorly correlated
-4.92%
RNXT - BAIVF
21%
Poorly correlated
+4.17%
CLYM - BAIVF
20%
Poorly correlated
+0.83%
GYRE - BAIVF
12%
Poorly correlated
+10.61%
More

CLYM and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLYM has been loosely correlated with RLYB. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if CLYM jumps, then RLYB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLYM
1D Price
Change %
CLYM100%
+0.83%
RLYB - CLYM
41%
Loosely correlated
-4.92%
LRMR - CLYM
31%
Poorly correlated
+10.00%
CLDX - CLYM
30%
Poorly correlated
+3.15%
ELVN - CLYM
30%
Poorly correlated
+5.19%
CMRX - CLYM
28%
Poorly correlated
+0.24%
More